An in silico and in vitro approach to elucidate the impact of residues flanking the cleavage scissile bonds of FVIII.
Coagulation Factor VIII is activated by an ordered limited thrombin proteolysis with different catalytic efficiency at three P1 Arginine residues: Arg759> Arg1708>Arg391, indicating the flanking residues of the latter to be less optimal. This study aimed to investigate, in silico and in vitro,...
Main Authors: | Behnaz Pezeshkpoor, Ursula Schreck, Arijit Biswas, Julia Driesen, Ann-Cristin Berkemeier, Anna Pavlova, Jens Müller, Johannes Oldenburg |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5500338?pdf=render |
Similar Items
-
FVIII Immunity : early events and tolerance mechanisms to FVIII
by: Qadura, Mohammad Imad
Published: (2008) -
Revisiting antithrombotic therapeutics; sculptin, a novel specific, competitive, reversible, scissile and tight binding inhibitor of thrombin
by: Asif Iqbal, et al.
Published: (2017-05-01) -
Flanking signal and mature peptide residues influence signal peptide cleavage
by: Ranganathan Shoba, et al.
Published: (2008-12-01) -
Acquired Hemophilia A (FVIII Deficiency) Associated with Papillary Thyroid Cancer: Treatment with Recombinant Porcine FVIII
by: S. Nguyen, et al.
Published: (2019-01-01) -
Restoration of FVIII expression by targeted gene insertion in the FVIII locus in hemophilia A patient-derived iPSCs
by: Jin Jea Sung, et al.
Published: (2019-04-01)